LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1521 | 4093 | 0.3717 | 0.1081 |
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3885 | 4093 | 0.9493 | 0.9280 |
MCF7 | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 1209 | 4339 | 4093 | 1.0601 | 1.0853 |
MCF7 | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3863 | 4093 | 0.9438 | 0.9202 |
MCF7 | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2856 | 4093 | 0.6979 | 0.5711 |
MCF7 | R406 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 4172 | 4093 | 1.0194 | 1.0275 |
MCF7 | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1604 | 4093 | 0.3919 | 0.1368 |
MCF7 | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3983 | 4093 | 0.9731 | 0.9619 |
MCF7 | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 1209 | 1510 | 4093 | 0.3690 | 0.1043 |
MCF7 | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1405 | 4093 | 0.3433 | 0.0678 |
MCF7 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3526 | 4093 | 0.8616 | 0.8036 |
MCF7 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3368 | 4093 | 0.8230 | 0.7488 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 1209 | 2269 | 4093 | 0.5544 | 0.3674 |
MCF7 | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1054 | 4093 | 0.2577 | -0.0537 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2286 | 4093 | 0.5586 | 0.3734 |
MCF7 | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1614 | 4093 | 0.3943 | 0.1403 |
MCF7 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3723 | 4093 | 0.9097 | 0.8718 |
MCF7 | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 2824 | 4093 | 0.6901 | 0.5601 |
MCF7 | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3944 | 4093 | 0.9638 | 0.9486 |
MCF7 | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3099 | 4093 | 0.7573 | 0.6555 |
MCF7 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 2618 | 4093 | 0.6396 | 0.4885 |
MCF7 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3460 | 4093 | 0.8455 | 0.7807 |
MCF7 | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 4506 | 4093 | 1.1010 | 1.1433 |
MCF7 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3771 | 4093 | 0.9214 | 0.8884 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2975 | 4093 | 0.7269 | 0.6124 |